Genes & biomarkers

IDH1 variants

IDH1 · IDH1 ≠ IDH2

IDH1 and IDH2 are different treatment targets despite their similar names.

Sources checked · Introductory guide

On this page

What does this result mean?

IDH1 encodes an enzyme involved in cell metabolism. Certain variants change its function and occur in cancers such as AML and bile duct cancer.[1]

How does it connect to treatment?

Ivosidenib is used in selected IDH1-mutated AML and previously treated bile duct cancers. Newly diagnosed versus relapsed disease and combination requirements differ by cancer.[2]

What should I check in my report?

Check whether the result is IDH1 or IDH2 and record the exact variant. Approval for another cancer with the same gene does not automatically establish eligibility.

Questions for your care team

  • Is my IDH1 variant actionable in my disease and treatment setting?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · IDH1 (opens in a new tab)
  2. NCI · ivosidenib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

IDH1 variants | Cancer Encyclopedia | My Chemo Diary